Literature DB >> 15004707

Cogan's syndrome: clinical evolution of deafness and vertigo in three patients.

A Baumann1, A Helbling, S Oertle, R Häusler, D Vibert.   

Abstract

The aim of this study was to evaluate the clinical symptoms, the otoneurological examinations, the treatment and the clinical course of three patients suffering from Cogan's syndrome, a rare disease based on the clinical association of a non-syphilitic interstitial keratitis with a cochleo-vestibular deficit. This case series involved three patients with follow up. The clinical course of the three patients (aged 30, 48 and 49 years) with Cogan's syndrome during a follow-up period of 2 to 6 years is reported. All patients underwent complete otoneurological, ophthalmologic and rheumatologic examinations and were treated with immunosuppressive therapy such as glucocorticoids and cyclophosphamide in two and glucocorticoids and methotrexate in one patient. Using immunosuppressive therapy, ophthalmologic symptoms disappeared rapidly in two patients. Hearing improved only in one and stabilized in a second patient. One patient died after 6 years of treatment because of complications of generalized vasculitis. Early diagnosis and rapid initiation of a combined immunosuppressive therapy such as corticosteroids and cyclophosphamide seem to be important in controlling the disease and avoiding persistent deafness. Whether systemic complications and a fatal outcome also can be prevented is still questionable.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004707     DOI: 10.1007/s00405-004-0738-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  25 in total

1.  Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms; a long-term follow-up.

Authors:  E W NORTON; D G COGAN
Journal:  AMA Arch Ophthalmol       Date:  1959-05

2.  Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan's syndrome.

Authors:  N B Allen; C C Cox; M Cobo; J Kisslo; M R Jacobs; R M McCallum; B F Haynes
Journal:  Am J Med       Date:  1990-03       Impact factor: 4.965

3.  Efficacy of methotrexate in Cogan's syndrome.

Authors:  L Riente; E Taglione; S Berrettini
Journal:  J Rheumatol       Date:  1996-10       Impact factor: 4.666

4.  Immunology of the inner ear: response of the inner ear to antigen challenge.

Authors:  J P Harris
Journal:  Otolaryngol Head Neck Surg       Date:  1983-02       Impact factor: 3.497

5.  Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature.

Authors:  B F Haynes; M I Kaiser-Kupfer; P Mason; A S Fauci
Journal:  Medicine (Baltimore)       Date:  1980-11       Impact factor: 1.889

6.  [Permeability of the round window membrane for prednisolone-21-hydrogen succinate. Prednisolone content of the perilymph after local administration vs. systemic injection].

Authors:  G Bachmann; J Su; C Zumegen; C Wittekindt; O Michel
Journal:  HNO       Date:  2001-07       Impact factor: 1.284

7.  Cogan's syndrome: clinical significance of antibodies against the inner ear and cornea.

Authors:  C Helmchen; V Arbusow; L Jäger; M Strupp; W Stöcker; P Schulz
Journal:  Acta Otolaryngol       Date:  1999       Impact factor: 1.494

8.  Clinical relevance of magnetic resonance imaging and computed tomography in Cogan's syndrome.

Authors:  M H Majoor; F W Albers; J W Casselman
Journal:  Acta Otolaryngol       Date:  1993-09       Impact factor: 1.494

9.  Hearing results of intratympanic steroid treatment of endolymphatic hydrops.

Authors:  M A Arriaga; S Goldman
Journal:  Laryngoscope       Date:  1998-11       Impact factor: 3.325

10.  Early corneal findings in Cogan's syndrome.

Authors:  L M Cobo; B F Haynes
Journal:  Ophthalmology       Date:  1984-08       Impact factor: 12.079

View more
  4 in total

1.  A novel therapeutic option in Cogan diseases? TNF-alpha blockers.

Authors:  M Fricker; A Baumann; F Wermelinger; P M Villiger; A Helbling
Journal:  Rheumatol Int       Date:  2007-03       Impact factor: 2.631

2.  Cogan syndrome with severe medium and large vessel vasculitis.

Authors:  Duriye D Sevgi; Lucia Sobrin; George N Papaliodis
Journal:  Digit J Ophthalmol       Date:  2015-02-01

3.  [Cogan's disease. Report of two cases].

Authors:  A Sandner; K Neumann; S Kösling; C Rasinski
Journal:  HNO       Date:  2010-07       Impact factor: 1.284

Review 4.  Optimal management of Cogan's syndrome: a multidisciplinary approach.

Authors:  Vittorio D'Aguanno; Massimo Ralli; Marco de Vincentiis; Antonio Greco
Journal:  J Multidiscip Healthc       Date:  2017-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.